Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses
First author：Xiaoling Liao
Corresponding author：Yongjun Wang
essential_information
- Person in charge：Xiaoling Liao
- Data Sources： TIMS-CHINA
- Number of papers：TIMS-CHINA20150132
- Published time：2014-09-01
2014-09-01
Published articles
Journal：STROKE
Publication type: Original Contributions
IF(IF): 7.914
PMID: 25013020 Link To Pubmed Full text Download
Background And Purpose
It remains uncertain whether lower dose intravenous tissue-type plasminogen activator (tPA) for stroke is as effective and safe as the standard dose